Mice with altered serotonin 2C receptor RNA editing display characteristics of Prader-Willi syndrome.
RNA transcripts encoding the 2C-subtype of serotonin (5HT(2C)) receptor undergo up to five adenosine-to-inosine editing events to encode twenty-four protein isoforms. To examine the effects of altered 5HT(2C) editing in vivo, we generated mutant mice solely expressing the fully-edited (VGV) isoform of the receptor. Mutant animals present phenotypic characteristics of Prader-Willi syndrome (PWS) including a failure to thrive, decreased somatic growth, neonatal muscular hypotonia, and reduced food consumption followed by post-weaning hyperphagia. Though previous studies have identified alterations in both 5HT(2C) receptor expression and 5HT(2C)-mediated behaviors in both PWS patients and mouse models of this disorder, to our knowledge the 5HT(2C) gene is the first locus outside the PWS imprinted region in which mutations can phenocopy numerous aspects of this syndrome. These results not only strengthen the link between the molecular etiology of PWS and altered 5HT(2C) expression, but also demonstrate the importance of normal patterns of 5HT(2C) RNA editing in vivo.
Morabito
Michael V
MV
Center for Molecular Neuroscience, Vanderbilt University, Nashville, TN 37232, USA; Department of Pharmacology, Vanderbilt University, Nashville, TN 37232, USA.
Abbas
Atheir I
AI
Hood
Jennifer L
JL
Kesterson
Robert A
RA
Jacobs
Michelle M
MM
Kump
David S
DS
Hachey
David L
DL
Roth
Bryan L
BL
Emeson
Ronald B
RB
D000818:Animals; D000831:Animals, Newborn; D004252:DNA Mutational Analysis; D004195:Disease Models, Animal; D005247:Feeding Behavior / Q000502:physiology; D005260:Female; D005786:Gene Expression Regulation / Q000235:genetics*; D018737:Hand Strength / Q000502:physiology; D006801:Humans; D007031:Hypothalamus / Q000378:metabolism; D008297:Male; D051379:Mice; D008822:Mice, Transgenic; D009154:Mutation / Q000235:genetics; D011218:Prader-Willi Syndrome / Q000235:genetics* / Q000473:pathology / Q000503:physiopathology; D011597:Psychomotor Performance / Q000502:physiology; D017393:RNA Editing / Q000235:genetics*; D012333:RNA, Messenger / Q000378:metabolism; D044405:Receptor, Serotonin, 5-HT2C / Q000235:genetics*
D012333:RNA, Messenger; D044405:Receptor, Serotonin, 5-HT2C
EMBO J. 1994 Jan 15;13(2):342-8
8313879
Front Neurosci. 2010 Mar 16;4:26
20582266
Neuron. 2008 Nov 26;60(4):582-9
19038216
Br J Pharmacol. 2001 Sep;134(2):386-92
11564657
Am J Hum Genet. 2002 Sep;71(3):669-78
12154412
Science. 2003 Aug 8;301(5634):832-6
12907802
Neuron. 2008 Mar 27;57(6):809-18
18367082
J Comput Biol. 2005 Oct;12(8):1047-64
16241897
Obes Res. 2002 Jun;10(6):541-50
12075603
Pediatrics. 2001 Nov;108(5):E92
11694676
Hum Nutr Clin Nutr. 1985 Sep;39(5):379-86
4055429
J Theor Biol. 1966 Sep;12(1):46-74
6015431
J Neurochem. 1966 Aug;13(8):655-69
5950056
J Biol Chem. 2007 Aug 3;282(31):22448-59
17567573
J Biol Chem. 1957 May;226(1):153-6
13428747
Endocrinology. 1999 Oct;140(10):4551-7
10499510
Proc Natl Acad Sci U S A. 2000 Dec 19;97(26):14311-6
11106375
Eur J Neurosci. 2007 May;25(10):3115-24
17561825
Metabolism. 1998 Apr;47(4):484-92
9550550
Diabetes. 1997 Dec;46(12):2119-23
9392508
J Biol Chem. 2004 Jan 23;279(4):2945-54
14602721
J Biol Chem. 1999 Apr 2;274(14):9472-8
10092629
Nat Genet. 2008 Jun;40(6):719-21
18500341
Am J Clin Nutr. 1988 May;47(5):815-21
2834941
PLoS One. 2008 Mar 05;3(3):e1709
18320030
Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):9258-63
10430930
Nat Med. 1998 Oct;4(10):1152-6
9771748
Hum Mol Genet. 1999 May;8(5):795-803
10196368
Gene. 1989 Apr 15;77(1):51-9
2744487
Nat Genet. 1999 May;22(1):15-6
10319852
Cell. 2002 Apr 19;109(2):145-8
12007400
J Neurosci. 2002 Dec 15;22(24):10529-32
12486144
Nature. 1989 Sep 7;341(6237):76-80
2788825
Hum Mol Genet. 2004 Dec 1;13(23):2971-7
15459179
Annu Rev Genomics Hum Genet. 2001;2:153-75
11701647
Mol Pharmacol. 1996 Oct;50(4):799-807
8863824
Am J Physiol. 1960 Aug;199:238-42
13760247
Hum Mol Genet. 2009 Sep 1;18(17):3257-65
19498035
Anal Chem. 2002 May 1;74(9):2003-7
12033299
J Neurosci. 2008 Nov 26;28(48):12834-44
19036977
Neurosci Lett. 2003 Aug 7;346(3):169-72
12853111
J Cell Biol. 2005 Jun 6;169(5):745-53
15939761
Nat Genet. 1992 Dec;2(4):270-4
1303278
Recent Prog Horm Res. 2004;59:395-408
14749511
Hum Mol Genet. 2000 Dec 12;9(20):3101-10
11115855
Neuropsychopharmacology. 1999 Aug;21(2 Suppl):82S-90S
10432493
Trends Endocrinol Metab. 2004 Jan-Feb;15(1):12-20
14693421
Mamm Genome. 2005 Jun;16(6):424-31
16075369
Mol Pharmacol. 2005 Sep;68(3):711-9
15917433
Hum Genet. 2005 Feb;116(3):228-30
15565282
Hum Mol Genet. 1999 Aug;8(8):1357-64
10400982
Nature. 1997 May 15;387(6630):303-8
9153397
Nucleic Acids Res. 2004 Apr 15;32(7):2113-22
15087490
PLoS Genet. 2007 Dec 28;3(12):e235
18166085
Anat Rec. 1999 Apr 15;257(2):64-72
10321434
Hum Mol Genet. 2009 Jun 15;18(12):2140-8
19304781
Nature. 1995 Apr 6;374(6522):542-6
7700379
Mol Psychiatry. 2008 Nov;13(11):1001-10
17848916
Nat Genet. 1999 Oct;23(2):199-202
10508517
Neuroscience. 1990;35(3):577-91
2381516
Science. 2006 Jan 13;311(5758):230-2
16357227
Neuropsychopharmacology. 2009 Sep;34(10):2237-51
19494808
Annu Rev Genet. 2000;34:499-531
11092837
J Neurochem. 2000 Mar;74(3):1290-300
10693963
Diabetes. 2003 Feb;52(2):315-20
12540602
J Neurosci. 2005 Jan 19;25(3):648-51
15659601
J Biol Chem. 2001 Nov 30;276(48):44663-8
11572865
Pharmacol Biochem Behav. 2002 Apr;71(4):691-700
11888560
Neuropsychopharmacology. 2001 May;24(5):478-91
11282248
Neurobehav Toxicol. 1979 Fall;1(3):233-6
551317
Nat Genet. 1998 May;19(1):25-31
9590284
Science. 2002 Jul 26;297(5581):609-11
12142539
Hum Mol Genet. 2007 Nov 15;16(22):2713-9
17728320